Professor Silvia Giordani, School of Chemical Sciences, received €1,206,941.90 for a project called “Bio-Inspired Functionalisation of Nanoplatforms for Targeted Delivery of Therapeutics.”

Nanoplatforms

I am deeply honoured to receive the SFI Frontiers for the Future grant. This recognition not only validates the hard work of my team but also underscores the potential impact of our research.

Our research is at the forefront of nanomedicine, focusing on developing innovative drug delivery systems using carbon nano-onions (CNOs). This technology aims to revolutionize the treatment of cancer by providing targeted, efficient, and low-dose therapies with minimal side effects. By improving the precision of drug delivery, our work has the potential to significantly enhance the quality of life for patients, reduce treatment costs, and increase the effectiveness of current medical interventions. The advancements in nanotechnology we are pursuing could pave the way for new diagnostic tools and therapeutic options, ultimately benefiting a broad range of health conditions.

I am grateful for the support from SFI and the confidence they have placed in our work. This grant will allow us to collaborate with leading experts, acquire cutting-edge technology, and accelerate our research. We are excited about the journey ahead and the positive changes our work can bring.